Literature DB >> 780375

The history of haemophilia.

G I Ingram.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 780375      PMCID: PMC476103          DOI: 10.1136/jcp.29.6.469

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  39 in total

1.  THE FORTUNES OF HAEMOPHILIACS IN THE NINETEENTH CENTURY.

Authors:  C B KERR
Journal:  Med Hist       Date:  1963-10       Impact factor: 1.419

2.  THE ROYAL HEMOPHILIA.

Authors:  V A MCKUSICK
Journal:  Sci Am       Date:  1965-08       Impact factor: 2.142

3.  The nomenclature of blood clotting factors.

Authors:  I S WRIGHT
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

4.  Equine haemophilia: report of a case and its response to multiple infusions of heterospecific AHG.

Authors:  H L NOSSEL; R K ARCHER; R G MACFARLANE
Journal:  Br J Haematol       Date:  1962-10       Impact factor: 6.998

5.  A female case of haemophilia.

Authors:  L GILCHRIST
Journal:  Proc R Soc Med       Date:  1961-09

6.  [Antihemophilic globulin (factor VIII) deficiency in Aland (Willebrand-Jürgens) thrombopathy].

Authors:  R JURGENS; W LEHMANN; O WEGELIUS; A W ERIKSSON; E HIEPLER
Journal:  Thromb Diath Haemorrh       Date:  1957-08-15

7.  The purification of antihaemophilic globulin from animal plasma.

Authors:  E BIDWELL
Journal:  Br J Haematol       Date:  1955-10       Impact factor: 6.998

8.  The Laboratory Diagnosis of Haemophilia.

Authors:  C Merskey
Journal:  J Clin Pathol       Date:  1950-11       Impact factor: 3.411

9.  HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

Authors:  A J Patek; F H Taylor
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

10.  HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETS.

Authors:  A J Patek; R P Stetson
Journal:  J Clin Invest       Date:  1936-09       Impact factor: 14.808

View more
  6 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs.

Authors:  D D Koeberl; C D Bottema; G Sarkar; R P Ketterling; S H Chen; S S Sommer
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

Review 3.  Progress and challenges in the development of a cell-based therapy for hemophilia A.

Authors:  M E Fomin; P P Togarrati; M O Muench
Journal:  J Thromb Haemost       Date:  2014-10-31       Impact factor: 5.824

4.  Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea.

Authors:  Byung Suk Moon; Jun Seok Choi; Chur Woo You
Journal:  Korean J Pediatr       Date:  2013-07-19

5.  Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity.

Authors:  Òscar Marín; Josu Aguirre; Xavier de la Cruz
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

Review 6.  The legacy of haemophilia: Memories and reflections from three survivors.

Authors:  Albert Farrugia; Cees Smit; Andrea Buzzi
Journal:  Haemophilia       Date:  2022-05-19       Impact factor: 4.263

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.